newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in